Cargando…
MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
MicroRNA (miR)-1246 is abnormally expressed and has pro-oncogenic functions in multiple types of cancer. In the present study, its functions in breast cancer and the underlying mechanisms were further elucidated. The clinical relevance of miR-1246 was analyzed and its expression in clinical specimen...
Autores principales: | Dai, Yue-chu, Pan, Yin, Quan, Ming-ming, Chen, Qi, Pan, Yue, Ruan, Yan-yun, Sun, Jian-guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671458/ https://www.ncbi.nlm.nih.gov/pubmed/34926237 http://dx.doi.org/10.3389/fonc.2021.677168 |
Ejemplares similares
-
Phenformin suppresses angiogenesis through the regulation of exosomal microRNA-1246 and microRNA-205 levels derived from oral squamous cell carcinoma cells
por: Zhuang, Dexuan, et al.
Publicado: (2022) -
The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus
por: Luo, Shuangyan, et al.
Publicado: (2015) -
A meta-analysis of the diagnostic value of microRNA-1246 for malignant tumors
por: Xie, Chunlin, et al.
Publicado: (2019) -
Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients
por: Hoshino, Isamu, et al.
Publicado: (2020) -
MicroRNA-1246 Promotes Melanoma Progression Through Targeting FOXA2
por: Yu, Yanhua, et al.
Publicado: (2020)